Moderna Inc (MRNA) — Financial Flexibility Index
Moderna Inc (MRNA) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of $-568.00 Million (operating CF $-630.00 Million minus capex $62.00 Million) represents 0% of total liabilities ($4.08 Billion). Check how strategically is Moderna Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Moderna Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Moderna Inc across 12 annual periods. See MRNA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Moderna Inc (2014–2025)
Year-by-year free cash flow to debt coverage for Moderna Inc. For the full company profile including market capitalisation, see MRNA company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.46x | $-1.68 Billion | $-1.87 Billion | $3.69 Billion | ▲ +24.4% |
| 2024 | -0.60x | $-1.95 Billion | $-3.00 Billion | $3.24 Billion | ▼ -14.3% |
| 2023 | -0.53x | $-2.41 Billion | $-3.12 Billion | $4.57 Billion | ▼ -166.0% |
| 2022 | 0.80x | $5.38 Billion | $4.98 Billion | $6.74 Billion | ▼ -39.5% |
| 2021 | 1.32x | $13.90 Billion | $13.62 Billion | $10.52 Billion | ▲ +201.3% |
| 2020 | 0.44x | $2.09 Billion | $2.03 Billion | $4.78 Billion | ▲ +142.5% |
| 2019 | -1.03x | $-427.41 Million | $-458.97 Million | $414.61 Million | ▼ -97.8% |
| 2018 | -0.52x | $-225.10 Million | $-330.87 Million | $431.91 Million | ▲ +12.4% |
| 2017 | -0.59x | $-273.08 Million | $-331.48 Million | $459.19 Million | ▼ -442.6% |
| 2016 | 0.17x | $99.88 Million | $66.73 Million | $575.31 Million | ▲ +104.0% |
| 2015 | -4.30x | $-738.15K | $-738.15K | $171.66K | ▼ -1122.5% |
| 2014 | -0.35x | $-4.78 Million | $-4.78 Million | $13.59 Million | — |